Ultrasound Guided Distal Sciatic Nerve Block - a Comparison With Nerve Stimulator Technique
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
For distal sciatic nerve block this prospective, randomised comparison with ultrasound guided distal subepineural block tested the hypothesis, that intraepineural injection of local anesthetic using nerve stimulation technique is common and associated with high success rate.
| Condition | Intervention |
|---|---|
|
Other Surgical Procedures |
Drug: midazolam Drug: Prilocaine 1% Drug: Ropivacaine 0.75% |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Treatment |
| Official Title: | Ultrasound Guided Distal Sciatic Nerve Block - a Randomised Comparison With Nerve Stimulator Technique |
- success rate [ Time Frame: within 30-60 minutes after injection of the local anesthetic ] [ Designated as safety issue: No ]
After injection of local anesthetic a waiting period of 30-60 minutes was defined before completing a failed block.
- success without supplementation = no additional analgetics or rescue blocks required
- success with supplementation = analgetics or selective rescue blocks distal of the sciatic division required
- failed block = change of anesthetic procedure (general, spinal) or rescue blocks proximal of the sciatic division
- time until readiness for surgery (minutes) [ Time Frame: within 60 minutes after injection of the local anesthetic ] [ Designated as safety issue: No ]
| Estimated Enrollment: | 250 |
| Study Start Date: | November 2010 |
| Estimated Study Completion Date: | August 2012 |
| Primary Completion Date: | December 2011 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Active Comparator: group US
Ultrasound guided block : 20ml Prilocaine 1% and 10ml Ropivacaine 0.75% (30ml Prilocaine 1% in outpatients) |
Drug: midazolam
Prior to performing the regional anesthesia the investigators administered midazolam as a premedication by mouth (3,75-7,5mg) or intravenously (2-3mg).
Other Name: Dormicum
Drug: Prilocaine 1%
20ml Prilocaine 1% for distal sciatic nerve block (30ml Prilocaine 1% in outpatients)
Other Name: Xylonest
Drug: Ropivacaine 0.75%
10ml Ropivacaine 0.75% for distal sciatic nerve block (not in outpatients)
Other Name: Naropin
Drug: Prilocaine 1%
10ml Prilocaine 1% for saphenous nerve block
Other Name: Xylonest
|
|
Active Comparator: group NS
Nerve stimulation technique: 20ml Prilocaine 1% and 10ml Ropivacaine 0.75% (30ml Prilocaine 1% in outpatients) |
Drug: midazolam
Prior to performing the regional anesthesia the investigators administered midazolam as a premedication by mouth (3,75-7,5mg) or intravenously (2-3mg).
Other Name: Dormicum
Drug: Prilocaine 1%
20ml Prilocaine 1% for distal sciatic nerve block (30ml Prilocaine 1% in outpatients)
Other Name: Xylonest
Drug: Ropivacaine 0.75%
10ml Ropivacaine 0.75% for distal sciatic nerve block (not in outpatients)
Other Name: Naropin
Drug: Prilocaine 1%
10ml Prilocaine 1% for saphenous nerve block
Other Name: Xylonest
|
Detailed Description:
Classical methods for nerve localization (loss of resistance, cause of paresthesias, nerve stimulation technique)assumed that the target is a close approximation to the nerve, without epineural perforation. Intraneural injections were considered as evitable, with high risk for nerve damages.
Ultrasound guidance provided for the first time a real-time visualization of the spread of local anesthetic. Some recent studies proved, that an intraneural injection using nerve stimulator technique is common and not necessarily accompanied with nerve damages.
In the ultrasound group (group US) the investigators tested the hypothesis, that an intraneural injection of local anesthetic generate a high success rate and a short onset time without clinical apparent nerve damages.
In the nerve-stimulation group (group NS) the investigators tested the hypothesis, that an intraneural injection of local anesthetic is common, and in case of intraneural injection accompanied likewise with high success rate and shorter onset time.
For the sciatic division the investigators tested the hypothesis, that classical methods of nerve localization (nerve-stimulation technique, cause of paresthesias) are not able to avoid epineural perforation.
Eligibility| Ages Eligible for Study: | 18 Years to 75 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- elective surgery on the foot or ankle
- tourniquet distal of the knee
- adult patients, 18-75 years old
- ASA-risk-groups I-III (American Society of Anesthesiologists)
- informed consent
Exclusion Criteria:
- severe coagulopathy
- systemic inflammatory response
- ASA-risk-groups > III
- drug allergy: local anesthetics
- pregnancy, lactation period
- participation in other studies
- addiction to drugs or alcohol
- non-cooperative patients
Contacts and Locations| Principal Investigator: | Ronald Seidel, Dr. med. | Klinik für Anästhesiologie und Intensivtherapie, Helios Kliniken Schwerin, Wismarsche Strasse 393-7, DE-19049 Schwerin |
| Study Director: | Georg Rehmert, Dr. med. | Klinik für Anästhesiologie und Intensivtherapie, Helios Kliniken Schwerin, Wismarsche Strasse 393-7, DE-19049 Schwerin |
More Information
No publications provided
| Responsible Party: | Dr.med.Ronald Seidel, Helios Research Center |
| ClinicalTrials.gov Identifier: | NCT01643616 History of Changes |
| Other Study ID Numbers: | HV 2010 003 |
| Study First Received: | July 16, 2012 |
| Last Updated: | July 22, 2012 |
| Health Authority: | Germany: Federal Institute for Drugs and Medical Devices |
Keywords provided by Helios Research Center:
|
Sciatic Nerve Ultrasound Anesthesia, Regional Orthopedic Surgery |
Additional relevant MeSH terms:
|
Prilocaine Ropivacaine Midazolam Anesthetics, Local Anesthetics Central Nervous System Depressants Physiological Effects of Drugs Pharmacologic Actions Sensory System Agents Peripheral Nervous System Agents Central Nervous System Agents Therapeutic Uses |
Adjuvants, Anesthesia Anti-Anxiety Agents Tranquilizing Agents Psychotropic Drugs Hypnotics and Sedatives Anesthetics, Intravenous Anesthetics, General GABA Modulators GABA Agents Neurotransmitter Agents Molecular Mechanisms of Pharmacological Action |
ClinicalTrials.gov processed this record on May 23, 2013